Belite Bio Statistics
NASDAQ: BLTEHealth CareBiotechnology: Pharmaceutical PreparationsUSD
156.08+0.47 (+0.30%)
At close: Oct 7, 4:00 PM ET · Delayed 15 min
Belite Bio by the numbers
Belite Bio has a market capitalization of $6.29 billion based on 40.27M shares outstanding. With trailing EPS of $-2.74, Belite Bio is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 5.8% below its 50-day average and 3.1% below its 200-day average.
Average daily trading volume is 182.25K shares, or about $28.4 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
BLTE valuation vs. peer median
| Metric | BLTE | Peer median | Difference |
|---|---|---|---|
| Market cap | $6.29B | $6.09B | +3% |
| Forward P/E | 69.1 | 23.6 | +192% |
| Avg. volume | 182.25K | 921.93K | -80% |
Peer median across 8 companies: RYTM, KNSA, LGND, AMRX, ALKS, SYRE, PTCT, MIRM.
Valuation
- Market cap
- $6.29B
- Forward P/E
- 69.06
- EPS (TTM)
- $-2.74
- Shares outstanding
- 40.27M
Price and trading
- Previous close
- 155.61
- Open
- 155.09
- Day range
- 155.00 – 156.49
- 52-week range
- 76.50 – 200.00
- 52-week change
- +101.65%
- 50-day moving average
- 165.74
- 200-day moving average
- 161.01
- Beta
- —
- Volume
- 97.80K
- Average volume
- 182.25K
Dividends and events
- Annual dividend
- None
- Next earnings date
- Aug 13, 2026
Additional statistics
- Market Cap
- 6.29B
- Forward Pe
- 69.06
- Eps
- -2.74
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 200.00
- Week52 Low
- 76.50
- Avg Volume
- 182.25K
- Shares Outstanding
- 40.27M
- Ma50
- 165.74
- Ma200
- 161.01
- Earnings Date
- Aug 13, 2026
- Pct From52w High
- -21.96%
- Pct From52w Low
- 104.03%